ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026
Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-β PET Drugs for Selection of Patients for Amyloid-β-Directed Therapies and Other Labeling Updates.
Hayoung Koo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.